Genmab A/S Expects 2023 Operating Expenses To Be In The Range Of DKK 10,600M – DKK 10,900M, An Increase To The Previous Guidance Of DKK 10,400M – DKK 10,900M
Portfolio Pulse from Benzinga Newsdesk
Genmab A/S has revised its 2023 operating expenses guidance to be in the range of DKK 10,600M – DKK 10,900M, up from the previous guidance of DKK 10,400M – DKK 10,900M.
November 07, 2023 | 4:28 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Genmab A/S has increased its 2023 operating expenses guidance, which could indicate higher costs or investments in the future.
The increase in operating expenses guidance could indicate that Genmab A/S is expecting higher costs or is planning to make more investments in the future. This could potentially impact the company's profitability, which might negatively affect the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100